본문으로 건너뛰기
← 뒤로

Integration of multi-omics data uncovers novel germline susceptibility candidates in early-onset colorectal cancer.

1/5 보강
European journal of human genetics : EJHG 2026
Retraction 확인
출처

López-Novo A, Amigo J, Dacal A, Remedios-Espino D, Cubiella J, Álvarez-Sánchez MV

📝 환자 설명용 한 줄

Colorectal cancer (CRC) is increasingly diagnosed in individuals under 50 years of age, yet the underlying genetic predisposition remains largely unexplained, particularly in mismatch repair (MMR)-pro

이 논문을 인용하기

↓ .bib ↓ .ris
APA López-Novo A, Amigo J, et al. (2026). Integration of multi-omics data uncovers novel germline susceptibility candidates in early-onset colorectal cancer.. European journal of human genetics : EJHG. https://doi.org/10.1038/s41431-025-02004-7
MLA López-Novo A, et al.. "Integration of multi-omics data uncovers novel germline susceptibility candidates in early-onset colorectal cancer.." European journal of human genetics : EJHG, 2026.
PMID 41540143 ↗

Abstract

Colorectal cancer (CRC) is increasingly diagnosed in individuals under 50 years of age, yet the underlying genetic predisposition remains largely unexplained, particularly in mismatch repair (MMR)-proficient cases. This study aimed to identify novel hereditary CRC susceptibility genes by integrating germline and tumour whole-exome sequencing (WES) with transcriptomic profiling across a cohort of early-onset CRC (EOCRC) patients. Tumours were categorised using Consensus Molecular Subtypes (CMS) classification and analysed for mutational signature and burden. We used a novel 'All vs One' multi-omic integration approach to identify loss-of-function rare germline variants with concordant gene expression alterations in tumour tissue. Five candidate genes (ADCY4, NOXO1, CDHR2, ARHGAP10, EEF2K) were prioritised based on this approach and potential biological relevance in CRC. These findings highlight the molecular heterogeneity of EOCRC and demonstrate the utility of multi-omic approaches in refining germline variant interpretation. Integrating tumour transcriptomics enhances gene discovery efforts and supports a more comprehensive understanding of CRC heritability in younger individuals.